Wealthfront Advisers LLC acquired a new stake in Trupanion, Inc. (NASDAQ:TRUP - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 17,529 shares of the financial services provider's stock, valued at approximately $845,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Amundi raised its stake in Trupanion by 193.2% in the fourth quarter. Amundi now owns 16,828 shares of the financial services provider's stock valued at $784,000 after buying an additional 11,088 shares during the period. Edgestream Partners L.P. bought a new stake in Trupanion in the fourth quarter valued at approximately $1,153,000. Inceptionr LLC bought a new stake in Trupanion in the fourth quarter valued at approximately $224,000. Raymond James Financial Inc. bought a new position in shares of Trupanion during the fourth quarter worth approximately $593,000. Finally, Proficio Capital Partners LLC bought a new position in shares of Trupanion during the fourth quarter worth approximately $976,000.
Insiders Place Their Bets
In related news, insider Brenna Mcgibney sold 5,000 shares of the business's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $32.99, for a total transaction of $164,950.00. Following the transaction, the insider now owns 3,738 shares in the company, valued at $123,316.62. The trade was a 57.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Fawwad Qureshi sold 1,373 shares of the business's stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total value of $46,984.06. Following the transaction, the chief financial officer now owns 2,416 shares in the company, valued at approximately $82,675.52. This represents a 36.24 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 25,984 shares of company stock valued at $850,362 over the last 90 days. Insiders own 5.50% of the company's stock.
Wall Street Analysts Forecast Growth
TRUP has been the topic of a number of recent research reports. Stifel Nicolaus lowered their target price on Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research note on Thursday, February 20th. Piper Sandler lowered their target price on Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research note on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $46.60.
Get Our Latest Stock Analysis on TRUP
Trupanion Trading Up 5.1 %
Shares of TRUP stock traded up $1.84 during mid-day trading on Wednesday, hitting $37.67. The company's stock had a trading volume of 608,400 shares, compared to its average volume of 642,996. The company's fifty day simple moving average is $42.15 and its 200-day simple moving average is $46.90. Trupanion, Inc. has a 52 week low of $19.69 and a 52 week high of $57.90. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. The company has a market cap of $1.60 billion, a PE ratio of -163.78, a P/E/G ratio of 6.02 and a beta of 1.70.
Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The business had revenue of $337.31 million during the quarter, compared to the consensus estimate of $335.41 million. As a group, equities research analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.
Trupanion Company Profile
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories

Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.